Sapio Sciences
| Company type | Private |
|---|---|
| Industry | Biotechnology software, Laboratory management systems |
| Founded | 2004 |
| Founder | Kevin Cramer |
| Headquarters | Baltimore , United States |
Key people | Kevin Cramer (Founder and CEO) |
| Products | Exemplar Analytics, Exemplar LIMS, Exemplar Dx LIMS, ELaiN AI Scientific Assistant |
Sapio Sciences is a technology company focused on creating software solutions that facilitate drug research and discovery processes. Founded in 2004 by Kevin Cramer, the firm specializes in laboratory management systems tailored for the biotechnology and chemistry industries.
History
Sapio Sciences was initially established to meet the increasing demand for genotyping tools used in Genome Wide Association Studies. This led to the development of Exemplar Analytics, which integrates more than 50 algorithms. Responding to client needs, the company launched Exemplar LIMS in 2007, a Laboratory Information Management System designed for compliance-driven environments such as part 11, GLP, and CLIA laboratories. The founder, Kevin Cramer, who studied Information Systems at York College, PA, has also contributed to scholarly work on applying machine learning techniques to genetic datasets.
In 2013, Sapio released Web Client 1.0 and by 2017 combined a web-based Electronic Lab Notebook (ELN) with its LIMS into a single platform. The Sapio Platform’s 2020 update introduced new modules aimed at data analysis and knowledge extraction, specifically crafted for life sciences sectors including biotechnology research and next-generation sequencing applications.
Among its distinguished clientele are NatureMetrics (2023), which employs Sapio’s technology for environmental DNA sequencing; Oxford Biomedica, focusing on cell and gene therapy research and development; and Immunebridge, utilizing the platform for managing NK cell immunotherapy data. In late 2023, Sapio unveiled ELaiN, the industry’s first AI-driven Scientific Assistant integrated within an Electronic Laboratory Notebook.
This evolution underscores Sapio Sciences’ growth trajectory through innovation in laboratory informatics, strategic product enhancements, and expanding global presence within regulated domains.
Operations
Sapio Sciences drives faster drug discovery by offering a unified laboratory platform equipped with integrated scientific applications and comprehensive data management capabilities. The platform includes components such as a web client, data designer, and workflow engine. Kevin Cramer serves as founder and CEO of the company.
Products
First introduced in 2007, Exemplar started as a combined LIMS and electronic laboratory notebook solution and has progressively incorporated additional functionalities. By 2008, it featured workflow automation and scientific data tracking for Scientific Data Management Systems (SDMS), along with advanced statistical tools for rigorous scientific evaluation.
Biomarker discovery
Exemplar was further developed to support biomarker discovery by handling complex datasets related to clinical studies, treatment groups, subjects, samples, and assays including Immunohistochemistry, Western Blotting, and PCR. It offers robust data mining alongside statistical analysis capabilities such as data normalization, logistic regression models, ANOVA tests, and genetic algorithm implementations.
Molecular diagnostics
The Exemplar Dx LIMS product is tailored specifically for molecular diagnostic laboratories to streamline test request processing and result management workflows. It seamlessly integrates with instruments from providers like Qiagen and Beckman Coulter, facilitates physician test ordering via web portals or HL7 message imports, and automates diagnostic report generation using customizable algorithms. These reports are electronically signed and securely transmitted through web portals, fax, HL7 messaging, or email delivery.